Addition of anacetrapib to statins lowers coronary events in ASCVD: REVEAL trial
UK: E Sammons, University of Oxford, Oxford, UK, and colleagues have found in a randomized controlled trial REVEAL that addition of cholesteryl ester transfer protein inhibitor therapy anacetrapib to...
United Kingdom Collaborative Group University Of Oxford Collaborative Group Writing Committee European Heart Group Writing Committee
Source: medicaldialogues.in